The high blood pressure drugs Benicar®, Benicar HCT®, Azor® and Tribenazor® have been linked to chronic diarrhea and kidney failure.
Drugmakers Daiichi Sankyo and Forest Laboratories have agreed to a $300 million settlement of multidistrict litigation by users of hypertension drug Benicar who linked their cases of severe diarrhea to use of the drug.
Attorneys placed the settlement on the record before U.S. District Judge Robert Kugler in Camden on Tuesday. The agreement would apply to about 2,000 cases from across the nation that were consolidated before Kugler, as well as another 100 cases pending in state Superior Court in Atlantic County.
READ MORE at New Jersey Law Journal
NEW YORK (Reuters) - Daiichi Sankyo on Tuesday said it has agreed to pay up to $300 million to settle some 2,300 U.S. cases accusing the Japanese drugmaker of failing to warn that its blood pressure medication Benicar can cause gastrointestinal illness.
The settlement will become finalized if at least 95 percent of all claimants agree, or opt in, Daiichi Sankyo said in a statement. The company said the settlement fund was capped at $300 million.
READ MORE at Reuters
Daiichi Sankyo Inc.’s settlement of thousands of lawsuits blaming the company’s blood-pressure drugs for causing intestinal damage brings to $339 million the amount the drugmaker has paid for its handling of the medicines.
Daiichi officials agreed Monday to pay $300 million to resolve patient suits over its Benicar, Benicar HCT, Azor and Tribenzor blood-pressure treatments. The accord comes more than two years after the Chuo-Ku, Japan-based company paid $39 million to resolve the U.S. government’s allegations that it paid illegal kickbacks to doctors who prescribed the medicines.
READ MORE at Bloomberg.com
Two years after Benicar lawsuits nationwide were centralized into one federal court in New Jersey, drug-makers Daiichi Sankyo and Forest Laboratories have agreed to pay a $300 million settlement.
The $300 million settlement will resolve about 2,300 lawsuits from people who developed a chronic intestinal illness known as sprue-like enteropathy after taking the blood pressure medication olmesartan in Benicar, Azor, or Tribenzor. The payouts for each plaintiff will depend on how many days they were hospitalized and the extent of their intestinal damage.
READ MORE at DailyHornet.com